Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125826271 | 12582627 | 1 | I | 20160629 | 20160715 | 20160722 | 20160722 | EXP | FR-ABBVIE-16P-056-1683056-00 | ABBVIE | 76.00 | YR | F | Y | 0.00000 | 20160722 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125826271 | 12582627 | 1 | PS | DEPAKOTE | DIVALPROEX SODIUM | 1 | Oral | Y | UNKNOWN | 18723 | 500 | MG | GASTRO-RESISTANT TABLET | BID | |||||
| 125826271 | 12582627 | 2 | SS | DEPAKOTE | DIVALPROEX SODIUM | 1 | Oral | Y | UNKNOWN | 18723 | 500 | MG | GASTRO-RESISTANT TABLET | TID | |||||
| 125826271 | 12582627 | 3 | SS | DEPAKOTE | DIVALPROEX SODIUM | 1 | Oral | Y | UNKNOWN | 18723 | 500 | MG | GASTRO-RESISTANT TABLET | BID | |||||
| 125826271 | 12582627 | 4 | SS | RISPERIDONE. | RISPERIDONE | 1 | Oral | Y | UNKNOWN | 0 | 2 | MG | QD | ||||||
| 125826271 | 12582627 | 5 | C | CALCIDOSE VITAMINE D | CALCIUMCHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 125826271 | 12582627 | 6 | C | CORDARONE | AMIODARONE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125826271 | 12582627 | 7 | C | KARDEGIC | ASPIRIN LYSINE | 1 | 0 | ||||||||||||
| 125826271 | 12582627 | 8 | C | LEVOTHYROX | LEVOTHYROXINE | 1 | 0 | ||||||||||||
| 125826271 | 12582627 | 9 | C | LOGIMAX | FELODIPINEMETOPROLOL SUCCINATE | 1 | 0 | ||||||||||||
| 125826271 | 12582627 | 10 | C | LOSARTAN POTASSIUM. | LOSARTAN POTASSIUM | 1 | 0 | ||||||||||||
| 125826271 | 12582627 | 11 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125826271 | 12582627 | 1 | Bipolar disorder |
| 125826271 | 12582627 | 4 | Product used for unknown indication |
| 125826271 | 12582627 | 5 | Product used for unknown indication |
| 125826271 | 12582627 | 6 | Product used for unknown indication |
| 125826271 | 12582627 | 7 | Product used for unknown indication |
| 125826271 | 12582627 | 8 | Product used for unknown indication |
| 125826271 | 12582627 | 9 | Product used for unknown indication |
| 125826271 | 12582627 | 10 | Product used for unknown indication |
| 125826271 | 12582627 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125826271 | 12582627 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125826271 | 12582627 | General physical health deterioration | |
| 125826271 | 12582627 | Hypotonia | |
| 125826271 | 12582627 | Malaise |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125826271 | 12582627 | 2 | 20160628 | 0 | ||
| 125826271 | 12582627 | 3 | 20160630 | 0 | ||
| 125826271 | 12582627 | 4 | 20160628 | 0 | ||
| 125826271 | 12582627 | 5 | 20160622 | 0 | ||
| 125826271 | 12582627 | 6 | 20160317 | 0 | ||
| 125826271 | 12582627 | 7 | 20160317 | 0 | ||
| 125826271 | 12582627 | 8 | 20160317 | 0 | ||
| 125826271 | 12582627 | 9 | 20160317 | 0 | ||
| 125826271 | 12582627 | 10 | 20160319 | 0 | ||
| 125826271 | 12582627 | 11 | 20160319 | 0 |